Modeling the TB/HIV-1 Co-Infection and the Effects of Its Treatment
Modeling the interaction of Tuberculosis (TB) and AIDS (HIV) drugs in the treatment of the TB/HIV co-infection shows that the treatment of Mtb (Mycobacterium tuberculosis) and AIDS improves. The administration of HIV drugs without TB drugs during co-infection favors the treatment of HIV, but the patient will eventually die of the Mtb opportunistic infection. Reducing the interaction of TB and HIV drugs and increasing the performance (efficiency of inhibition) of Reverse Transcriptase Inhibitors (RTIs) in CD4+ T cells improves the treatment of HIV and leads to the preferential replication of HIV particles in macrophages. The simultaneous administration of TB and HIV drugs is to be recommended for it prevents patients from dying of the Mtb opportunistic infection.
Volume (Year): 17 (2010)
Issue (Month): 1 ()
|Contact details of provider:|| Web page: http://www.tandfonline.com/GMPS20|
|Order Information:||Web: http://www.tandfonline.com/pricing/journal/GMPS20|
When requesting a correction, please mention this item's handle: RePEc:taf:mpopst:v:17:y:2010:i:1:p:12-64. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Michael McNulty)
If references are entirely missing, you can add them using this form.